ARCHIVES

DCT Board Approves Concept Of Contract Recompetitions Worth $5.1 Million A Year

This article is from The Cancer Letter archive.

Vol. 07 No. 28 | July 10, 1981

Download PDF Visit The Full Archive

Related Articles

Duke Deans Acknowledge Withholding Key Document From Outside Reviewers

January 14, 2011

NCI Considers Seeking New Study Section For Clinical Research, Or Expansion Of E2

November 23, 1990

Funding Opportunities: CAM Research Center Applications Sought.

January 3, 2003

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

Studies Are Demonstrating Effectiveness Of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 12, 1974

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976